Ginkgo Bioworks was founded with the mission to make biology easier to engineer. They have built the world's first organism engineering foundry in Boston and have an outstanding team bringing new organisms to customers.
PUBLIC VIA SPAC IN 2021, NYSE: DNA
INVESTMENT IN 2014
Operators at Ginkgo shuttle samples between workstations on the foundry floor.
Featured
Gingko partners with Pfizer in its first drug discovery deal for RNA medicines